In these assays, SERINC5’s ability to reduce the infectivity of HIV-1 Δnef particles is associated with its incorporation into virions, which reduces the Env-mediated capacity to fuse with target cells during the next round of infection. The gene discussed is SERINC5; the disease is infection.